DOLAM-500: Efficacy and safety of Dolutegravir (DTG) plus Lamivudine (3TC) in ART-naive PLWH with baseline viral load ?500,000 copies/mL

Basit Öğe Kaydı
dc.contributor.authorInan, A.
dc.contributor.authorAkhan, S.
dc.contributor.authorKaya, B.
dc.contributor.authorToker, A. Kilinc
dc.contributor.authorTasova, Y.
dc.contributor.authorKaraoglan, I.
dc.contributor.authorSarlak, P.
dc.date.accessioned2024-04-24T17:49:54Z
dc.date.available2024-04-24T17:49:54Z
dc.date.issued2023
dc.departmentDicle Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.endpage184en_US
dc.identifier.issn1464-2662
dc.identifier.issn1468-1293
dc.identifier.startpage184en_US
dc.identifier.urihttps://hdl.handle.net/11468/23076
dc.identifier.volume24en_US
dc.identifier.wosWOS:001174349600181
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofHiv Medicine
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titleDOLAM-500: Efficacy and safety of Dolutegravir (DTG) plus Lamivudine (3TC) in ART-naive PLWH with baseline viral load ?500,000 copies/mLen_US
dc.titleDOLAM-500: Efficacy and safety of Dolutegravir (DTG) plus Lamivudine (3TC) in ART-naive PLWH with baseline viral load ?500,000 copies/mL
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu